Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Gamma-aminobutyric acid receptor subunit beta-2 (GABRB2) is a fundamental component of the GABA_A receptor, the primary inhibitory neurotransmitter receptor in the mammalian brain (UniProt: P47870). As a member of the Cys-loop ligand-gated ion channel family, it typically forms a pentameric complex with alpha and gamma subunits to create a chloride-selective channel (NCBI Gene: 2561). This subunit is widely distributed in the central nervous system and is crucial for maintaining the balance between neuronal excitation and inhibition (PMID: 28813301).\n\nMutations in the GABRB2 gene are clinically significant, often associated with epilepsy syndromes, febrile seizures, and psychiatric conditions like schizophrenia (PMID: 30135574). Pharmacologically, the beta-2 subunit is a critical site for the action of general anesthetics such as propofol and etomidate, which enhance GABA-mediated inhibition (PubChem: 4943). Additionally, it mediates the effects of certain anticonvulsants and sedatives, making it a focal point for developing therapies for sleep disorders and anxiety (PMID: 11160514). Understanding the specific role of GABRB2 helps in the design of subtype-selective drugs that aim to minimize side effects like excessive sedation or respiratory depression (StatPearls: NBK513311).
Positive allosteric modulation of the GABA-A receptor complex, increasing chloride conductance and hyperpolarizing neurons (StatPearls: NBK513311).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gamma-aminobutyric acid receptor subunit beta-2 (GABRB2) (GABRB2).